Effect of Quyu Chencuo Formula (去菀陈莝方) on Renal Fibrosis in Obstructive Nephropathy Rats
Back to article page
Original Article|Updated:2021-08-27
|
Effect of Quyu Chencuo Formula (去菀陈莝方) on Renal Fibrosis in Obstructive Nephropathy Rats
Effect of Quyu Chencuo Formula (去菀陈莝方) on Renal Fibrosis in Obstructive Nephropathy Rats
Chinese Journal of Integrative Medicine2019年25卷第3期 页码:190-196
Affiliations:
Department of Traditional Chinese Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan (430022), China
Author bio:
Correspondence to: Prof. YANG Sheng-lan, Tel: 86-18671913111, E-mail: yangshenglan@126.com
Funds:
the National Natural Science Foundation of China(30973834;81102692)
Rui ZHU, Xing-guo DU, Sheng-lan YANG, 等. Effect of Quyu Chencuo Formula (去菀陈莝方) on Renal Fibrosis in Obstructive Nephropathy Rats[J]. Chinese Journal of Integrative Medicine, 2019,25(3):190-196.
Rui ZHU, Xing-guo DU, Sheng-lan YANG, et al. Effect of Quyu Chencuo Formula (去菀陈莝方) on Renal Fibrosis in Obstructive Nephropathy Rats[J]. Chinese Journal of Integrative Medicine, 2019,25(3):190-196.
Rui ZHU, Xing-guo DU, Sheng-lan YANG, 等. Effect of Quyu Chencuo Formula (去菀陈莝方) on Renal Fibrosis in Obstructive Nephropathy Rats[J]. Chinese Journal of Integrative Medicine, 2019,25(3):190-196. DOI: 10.1007/s11655-015-2133-2.
Rui ZHU, Xing-guo DU, Sheng-lan YANG, et al. Effect of Quyu Chencuo Formula (去菀陈莝方) on Renal Fibrosis in Obstructive Nephropathy Rats[J]. Chinese Journal of Integrative Medicine, 2019,25(3):190-196. DOI: 10.1007/s11655-015-2133-2.
Effect of Quyu Chencuo Formula (去菀陈莝方) on Renal Fibrosis in Obstructive Nephropathy Rats
摘要
Abstract
Objective:
2
To observe the effect of Quyu Chencuo Formula (去菀陈莝方
QCF) on renal fibrosis in rats with obstructive nephropathy.
Methods:
2
Twenty-four rats were randomly divided into three groups
4 for sham operation as the control group
10 for unilateral ureteral obstruction (UUO) model group
and the rest 10 for QCF treating UUO model group. All rats were sacrificed under 3% pentobarbital (50 mg/kg) anesthesia on the 14th day after surgery
then the right kidney samples of rats were harvested for hematoxylin eosin (HE) staining and Masson staining to observe the renal pathological changes. Immunohistochemistry and Western blotting were used to examine the expression of transforming growth factor β1 (TGF-β1)
and real-time polymerase chain reaction (RT-PCR) was employed to examine the expressions of TGF-β1
α-smooth muscle actin (α-SMA) and E-cadherin mRNA.
Results:
2
HE and Masson staining showed that the renal interstitial of the rats in the control group had no significant fibrotic lesion; in the model group
there were obvious interstitial fibrosis; for the QCF group
there were epithelial cell necrosis
infiltration of lymphocytes and mononuclear cells
aggravated interstitial fibrosis in varied degrees
but the pathological changes were less in the QCF group than in the model group. The immunohistochemistry and Western blotting results showed that the TGF-β1 expression was increased significantly in the model group
while decreased significantly in the QCF group (
P
<
0.05); RT-PCR showed that the mRNA expression of α-SMA and TGF-β1 increased significantly in the model group
while both were significantly decreased in the QCF group compared with the model group (
P
<
0.05). The mRNA expression of E-cadherin was decreased significantly in the model group
and it was significantly increased in the QCF group as compared with the model group (
P
<
0.05).
Conclusion:
2
QCF may improve renal fibrosis by regulating the expressions of TGF-β1
Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini
Immunomodulatory Function of Pien Tze Huang in T Cell-Mediated Anti-tumor Activity against B16-F10, MC38 and Hep1-6 Tumor Models
Safflower Yellow Inhibits Progression of Hepatocellular Carcinoma by Modulating Immunological Tolerance via FAK Pathway
Immunoregulatory and Anti-cancer Activities of Combination Treatment of Novel Four-Herb Formula and Doxorubicin in 4T1-Breast Cancer Bearing Mice
TRAIL and Celastrol Combinational Treatment Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells via Targeting Wnt/β-Catenin Signaling Pathway
相关作者
暂无数据
相关机构
Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine
State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Science, Xiamen University
Fujian Pien Tze Huang Enterprise Key Laboratory of Natural Medicine Research and Development
Department of General Surgery, First People's Hospital of Hangzhou Lin'an District
Institute of Chinese Medicine, The Chinese University of Hong Kong